Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients
Aaron Boothby(University of Washington), Sandhya R. Panch(University of Washington), John R. Hess(Harborview Medical Center), Ralph R. Vassallo(Vitalant), Lauge Sokol‐Hessner(University of Washington), Thejaswi Bikkani(University of Washington), Nuri Cha(National Institutes of Health Clinical Center), Idoia Gimferrer(Bloodworks Northwest), Abdullah Alswied(National Institutes of Health Clinical Center), Danny Youngs, Michael G. Nash(University of Washington), Terry Gernsheimer(Bloodworks Northwest), Hamilton C. Tsang(University of Washington), David F. Stroncek(Yale University), Matthew Tanner(University of Washington), Snigdha Marivada(Nova Southeastern University), Josefine Bribiesca Rodriguez(University of Washington), Willy A. Flegel(National Institutes of Health Clinical Center)
Cited by 9
Related Papers
Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma
|JAMA|2015|2.5k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Molecular Basis of Weak D Phenotypes
|Blood|1999|336
Molecular Basis of Weak D Phenotypes
|Blood|1999|331